Nanophthalmic uveal effusion managed with scleral windows and topical mitomycin-C.

Abstract

The authors treated a 38-year-old man with nanophthalmic uveal effusion with scleral windows and local application of mitomycin-C. The patient underwent two separate surgical procedures, involving placement of scleral windows in all four quadrants and topical application of mitomycin-C in one quadrant. Episcleral scarring led to closure of scleral windows in all quadrants except one quadrant where mitomycin-C was applied during the first surgery. The uveal effusion resolved following the second surgery. No complications related to mitomycin-C were observed. Topical mitomycin-C may be a useful adjunct in the surgical management of uveal effusion syndrome.

Cite this paper

@article{Akduman1997NanophthalmicUE, title={Nanophthalmic uveal effusion managed with scleral windows and topical mitomycin-C.}, author={Levent Akduman and Dr. Edward A. Adelberg and Lucian V. Del Priore}, journal={Ophthalmic surgery and lasers}, year={1997}, volume={28 4}, pages={325-7} }